Uthealth Houston
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1967-01-01
- Employees
- 11
- Market Cap
- -
Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention
Not Applicable
Completed
- Conditions
- Increase HPV Vaccination UptakeDelay Sexual Debut
- Interventions
- Behavioral: Families Talking Together Plus (FTT+HPV)Behavioral: Brief motivational interviewing (BMI)
- First Posted Date
- 2015-11-09
- Last Posted Date
- 2023-11-03
- Target Recruit Count
- 1183
- Registration Number
- NCT02600884
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma
Phase 1
Withdrawn
- Conditions
- Pancreatic Adenocarcinoma
- Interventions
- Device: Electroporation
STEPs to Blood Pressure Reduction.
Not Applicable
Terminated
- Conditions
- Blood Pressure ReductionStroke Prevention
- Interventions
- Behavioral: Usual CareBehavioral: STEP Clinic
- First Posted Date
- 2015-10-29
- Last Posted Date
- 2020-09-10
- Target Recruit Count
- 115
- Registration Number
- NCT02591394
- Locations
- 🇺🇸
University of Texas Health Science Center at Houston, Houston, Texas, United States
The neoClose Abdominal Closure vs Carter-Thomason Trial
Not Applicable
Completed
- Conditions
- Surgical Port Site Hernia
- Interventions
- Device: Neo Close Abdominal ClosureDevice: Carter Thomason Device
- First Posted Date
- 2015-10-28
- Last Posted Date
- 2019-08-28
- Target Recruit Count
- 70
- Registration Number
- NCT02589171
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury
Not Applicable
Completed
- Conditions
- Neurogenic BladderSpinal Cord Injury
- Interventions
- Device: Transcutaneous Tibial Nerve StimulationDevice: Control
- First Posted Date
- 2015-10-09
- Last Posted Date
- 2018-09-10
- Target Recruit Count
- 19
- Registration Number
- NCT02573402
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer
Phase 2
Terminated
- Conditions
- Urinary Bladder Neoplasms
- Interventions
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2018-11-28
- Target Recruit Count
- 3
- Registration Number
- NCT02560038
- Locations
- 🇺🇸
UTHealth Memorial Hermann Cancer Center, Houston, Texas, United States
Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
Phase 2
Terminated
- Conditions
- Carcinoma, Renal Cell
- Interventions
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2018-10-12
- Target Recruit Count
- 4
- Registration Number
- NCT02560012
- Locations
- 🇺🇸
UTHealth Memorial Hermann Cancer Center, Houston, Texas, United States
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer
Phase 2
Terminated
- Conditions
- Prostatic Neoplasms
- Interventions
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2018-11-28
- Target Recruit Count
- 19
- Registration Number
- NCT02560051
- Locations
- 🇺🇸
UTHealth Memorial Hermann Cancer Center, Houston, Texas, United States
Randomized Control Trial (RCT) of Early Palliative Care for HCC
Not Applicable
- Conditions
- Carcinoma, Hepatocellular
- Interventions
- Behavioral: Early Palliative Care/Symptom Control
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2021-04-27
- Target Recruit Count
- 72
- Registration Number
- NCT02556619
- Locations
- 🇺🇸
Lyndon Baines Johnson (LBJ) General Hospital, Houston, Texas, United States
The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2018-06-06
- Target Recruit Count
- 60
- Registration Number
- NCT02544984
- Locations
- 🇺🇸
High Risk Children's Clinic, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath